Nanomedicine in Cancer Immunotherapy
- 1st Edition - January 11, 2024
- Latest edition
- Editor: Prashant Kesharwani
- Language: English
Nanomedicine in Cancer Immunotherapy bridges the two disciplines of nanotechnology and immunology, summarizing the latest research into novel cancer treatments, often person… Read more
Description
Description
Nanomedicine in Cancer Immunotherapy bridges the two disciplines of nanotechnology and immunology, summarizing the latest research into novel cancer treatments, often personalized to the patient. The book covers a wide range of nanomaterial types for use in cancer immunotherapy, including hydrogel, lipid, exosome, gold and peptide nanoparticles. The preparation, application, pros and cons of each nanomaterial class is reviewed, helping the reader understand the potential for each to tailor their own selections. Nanovaccines are also covered, along with a clinical evaluation and market analysis of nanomedicines for immunotherapy, offering an important clinical and commercial overview of this rapidly developing field.
This book is an interesting reference for those working in the fields of nanotechnology, immunology, and cancer therapeutics, as well as clinicians with an interest in novel nano-based cancer treatments.
This book is an interesting reference for those working in the fields of nanotechnology, immunology, and cancer therapeutics, as well as clinicians with an interest in novel nano-based cancer treatments.
Key features
Key features
- Provides a single source for a review of the latest research in the development of nanomaterials for cancer immunotherapy
- Introduces the reader to basic principles of immunology and immunotherapy to aid our understanding
- Details a wide range of nanomaterial classes for cancer immunotherapy, with advantages and disadvantages thoroughly analyzed
Readership
Readership
Researchers and postgraduate students in the fields of materials science, biomedical engineering, pharmaceutical science and nanotechnology, Clinical scientists and R&D groups developing novel materials for biomedical applications
Table of contents
Table of contents
1. Immunoadjuvants for cancer immunotherapy
2. Nanotechnology as an emerging option in cancer immunotherapy
3. Different administration routes for nanovectors in cancer immunotherapy
4. Two-dimensional materialbased nanomedicines for cancer immunotherapy
5. Hydrogel-based nanomedicines for cancer immunotherapy
6. Exosomes-based nanomedicines for cancer immunotherapy
7. Lipid-based nanomedicines for cancer immunotherapy
8. Inorganic nanoparticle-based nanomedicines for cancer immunotherapy
9. Liposome-based nanomedicines for cancer immunotherapy
10. Biomembrane-based nanoparticles for cancer immunotherapy
11. Dendrimer-based nanomedicines for cancer immunotherapy
12. Magnetic nanocarriers for cancer immunotherapy
13. Inhaled delivery of immunotherapy for treatment of lung cancer
14. Nano-based vaccination and their administration routes in cancer immunotherapy
15. Current status, challenges, and future perspective of nanomedicine-based cancer immunotherapy
2. Nanotechnology as an emerging option in cancer immunotherapy
3. Different administration routes for nanovectors in cancer immunotherapy
4. Two-dimensional materialbased nanomedicines for cancer immunotherapy
5. Hydrogel-based nanomedicines for cancer immunotherapy
6. Exosomes-based nanomedicines for cancer immunotherapy
7. Lipid-based nanomedicines for cancer immunotherapy
8. Inorganic nanoparticle-based nanomedicines for cancer immunotherapy
9. Liposome-based nanomedicines for cancer immunotherapy
10. Biomembrane-based nanoparticles for cancer immunotherapy
11. Dendrimer-based nanomedicines for cancer immunotherapy
12. Magnetic nanocarriers for cancer immunotherapy
13. Inhaled delivery of immunotherapy for treatment of lung cancer
14. Nano-based vaccination and their administration routes in cancer immunotherapy
15. Current status, challenges, and future perspective of nanomedicine-based cancer immunotherapy
Product details
Product details
- Edition: 1
- Latest edition
- Published: January 11, 2024
- Language: English
About the editor
About the editor
Prashant Kesharwani
Editor
Dr. Prashant Kesharwani, PhD, is an Assistant Professor of Pharmaceutics at Department of Pharmaceutical Sciences, Dr.
Harisingh Gour Vishwavidyalaya University, Sagar, Madhya Pradesh, India. He has more than 12 years of teaching, research,
and industrial experience across various countries. An overarching goal of his current research is the development of
nanoengineered drug delivery systems for various diseases. He has more than 400 international publications in well-reputed
journals and more than 30 international books (Elsevier). His work has garnered 40,000 + citations, with an h-index of above
100, making him one of the youngest Indian researchers to achieve an h-index of 100 at the age of 41. He is a recipient
of many research grants from various funding bodies. He is also the recipient of several internationally acclaimed awards,
such as “USERN Laureate award” and “SERB-Ramanujan Fellowship Award.” He has presented many invited talks and oral
presentations at prestigious scientific peer-conferences, received international acclaims and awards for research contribution,
supervised students/junior researchers, and actively participated in outreach and scientific dissemination for the service of
the wider community.
Affiliations and expertise
Dr. Harisingh Gour Vishwavidyalaya University, IndiaView book on ScienceDirect
View book on ScienceDirect
Read Nanomedicine in Cancer Immunotherapy on ScienceDirect